US Stock MarketDetailed Quotes

APTO Aptose Biosciences

Watchlist
  • 0.2790
  • +0.1088+63.92%
Close Dec 20 16:00 ET
  • 0.2250
  • -0.0540-19.35%
Post 20:01 ET
16.61MMarket Cap-0.10P/E (TTM)

About Aptose Biosciences Company

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Company Profile

SymbolAPTO
Company NameAptose Biosciences
Listing DateOct 23, 2014
Founded1986
CEODr. William G. Rice, PhD
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
AddressTD Bank Tower,66 Wellington Street West,Suite 5300
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM5K 1E6
Phone1-647-479-9828
Websitehttp://www.aptose.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William G. Rice, PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 924.67K
  • Fletcher Payne
  • Principal Accounting Officer, Senior Vice President, Chief Financial Officer, Corporate Secretary and Chief Business Officer
  • 611.37K
  • Dr. Rafael Bejar, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 750.08K
  • Dr. Mark D. Vincent, M.D.
  • Independent Director
  • 127.68K
  • Dr. Erich M. Platzer, M.D.,PhD
  • Independent Director
  • 123.67K
  • Carol Gail Ashe
  • Independent Director
  • 123.67K
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • 132.17K
  • Warren Whitehead
  • Independent Director
  • 122.68K
  • Dr. Denis R. Burger,PhD
  • Lead Independent Director
  • 172.17K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%